The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial

Stephen M. Stick*, Alexia Foti, COMBAT CF Study Group, Robert S. Ware, Harm A.W.M. Tiddens, Barry S. Clements, David S. Armstrong, Hiran Selvadurai, Andrew Tai, Peter J. Cooper, Catherine A. Byrnes, Yvonne Belessis, Claire Wainwright, Adam Jaffe, Philip Robinson, Lisa Saiman, Peter D. Sly

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial'. Together they form a unique fingerprint.

Nursing and Health Professions

Medicine and Dentistry